Alnylam Pharmaceuticals
ALNY
#458
Rank
โ‚น4.648 T
Marketcap
โ‚น35,187
Share price
-5.85%
Change (1 day)
63.16%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company